Table 1.
Correlation between the expression level of FER1L4 and clinicopathological features in 80 PTC patients
| Characteristics | Cases (%) | FER1L4 expression | P value* | |
|---|---|---|---|---|
| n = 80 | Low (n = 40) | High (n = 40) | ||
| Age (year) | ||||
| ≤ 45 | 43 (53.75) | 23 | 20 | 0.327 |
| > 45 | 37 (46.25) | 17 | 20 | |
| Gender | ||||
| Male | 18 (22.50) | 8 | 10 | 0.395 |
| Female | 62 (77.5) | 32 | 30 | |
| Tumor size (cm) | ||||
| ≤ 2 | 69 (86.25) | 37 | 32 | 0.096 |
| > 2 | 11 (13.75) | 3 | 8 | |
| Lymph node metastasis | ||||
| N0 | 32 (40.00) | 21 | 11 | 0.020 |
| N1a + N1b | 48 (60.00) | 19 | 29 | |
| Extrathyroidal extension | ||||
| Yes | 12 (15.00) | 2 | 10 | 0.013 |
| No | 68 (85.00) | 38 | 30 | |
| TNM stage | ||||
| I + II | 63 (78.75) | 36 | 27 | 0.013 |
| III + IV | 17 (21.25) | 4 | 13 | |
* Chi-square detection
Significant results were in bold